Medical
Stay up-to-date on the latest medical cannabis research, news, and information with Business of Cannabis. Learn about new treatments, laws, and more.
Medical · page 71
- CBD Market
Germany Needs Workable Adult-Use Legislation Capable Of Drying-Up The Illicit Market.
Leading German Cannabis Lawyer Kai-Friedrich Niermann reflects on 2021 and looks ahead to the challenges and opportunities that lie ahead in 2022 BC: What are the main opportunities and challenges for the European cannabis industry in 2022 K-FN: The cannabis industry in Europe in its various sectors – medical, commercial hemp and CBD – has…
- Companies
Structure change to drive the growth of Broughton
Broughton is restructuring its management in a bid to drive the growth of the company.
- Medical
Glass Pharms: initiating domestic supply of medical cannabis in the UK
Glass Pharms will begin the domestic supply of medical cannabis in the UK from the world’s first carbon-negative cannabis cultivation facility.
- Pharmaceutical
Youth not wasted, government-run stores not selling, no mailing vape and dank-e
Youth cannabis use ‘decreased significantly’ in 2021 A federally funded survey revealed that, despite an increasing number of states opening up legal sales, youth consumption of cannabis and illicit substances overall has decreased through the pandemic, reports Marijuana Moment.
- Press releases
Materia Malta Commences First Sales of Medical Cannabis in Europe
Kanabo Group Plc (LSE:KNB), a medical cannabis and R&D Company that focuses on the distribution of cannabis-derived products for medical patients and wellness CBD consumers, notes that Materia’s wholly-owned subsidiary Materia Malta Operating Ltd. (“Materia Malta“) has commenced sales in Europe of the first medical cannabis flower produced at its EU GMP certified manufacturing site.
- Medical
Materia Malta begins its first European medical cannabis sales
The company’s medical cannabis flower is now available in Malta pharmacies.
- Pharmaceutical
Pfizer enters medical cannabis market with new acquisition
Pharma titan Pfizer is to acquire Arena Pharmaceuticals which has a pipeline in cannabinoid therapeutics.
- CBD Market
Mo’ money, cannabis research, the canna-verse and THC in the EU
Capital raises in cannabis exceed pre-pandemic levels to $10+ billion Cannabis industry capital raises exceeded pre-pandemic levels in 2021, with $10.1 billion raised in the first three quarters of the year, according to New Frontier Data’s new report, Cultivating Capital: Cannabis Finance & Investment, released in partnership with FTI Consulting.
- Your #1 Podcast on Cannabis News
Bridging legal markets with a premium cannabis platform
On this episode of BofC Live, we connect with Oren Shuster, the CEO of IM Cannabis – a cannabis operator with footprints in Israel, Canada and Germany.
- Medical
Portfolio of doseable cannabis products launched in the UK
The products will allow patients to administer metered doses of their medicines.
- CBD Market
2022 plans for HEXO, California and UK CBD
HEXO reports $116.9-million loss, launches new Path Forward plan Quebec-based HEXO reported a $116.9 million loss in its first quarter and announced a new strategic plan called A Path Forward, reports Yahoo Finance.
